The following section enumerates potentially important adverse events that have occurred in clinical practice and that have been reported spontaneously to various surveillance systems. The events enumerated represent reports arising from both domestic and nondomestic use of oral or subcutaneous dosage forms of sumatriptan. The events enumerated include all except those already listed in the ADVERSE REACTIONS section above or those too general to be informative. Because the reports cite events reported spontaneously from worldwide postmarketing experience, frequency of events and the role of sumatriptan in their causation cannot be reliably determined. It is assumed, however, that systemic reactions following sumatriptan use are likely to be similar regardless of route of administration.
For Patients, Family, Caregivers:
ADAPT Pharma is committed to making NARCAN ® Nasal Spray affordable and accessible to everyone. ADAPT has entered into collaborations with wholesalers, distributors, and retail pharmacies to ensure broad-based availability. ADAPT has also entered into agreements with major Pharmacy Benefits Managers and insurance companies (including Medicaid) to make sure the cost to the patient is reasonable and affordable. In fact, 94% of insured lives in the . have coverage for NARCAN ® Nasal Spray.*